RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma

RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer

(2014) Jin-Qiu Xue et al.   BMC CANCER

Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors

(2014) Jin Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting p53 for Novel Anticancer Therapy

(2014) Zhen Wang et al.   Translational Oncology

Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma

(2013) J.-L. Huang et al.   CARCINOGENESIS

Non-Cell-Autonomous Tumor Suppression by p53

(2013) Amaia Lujambio et al.   CELL

Recent Advancements in Comprehensive Genetic Analyses for Human Hepatocellular Carcinoma

(2013) Naoshi Nishida et al.   ONCOLOGY

Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma

(2012) Igor P. Pogribny et al.   CANCER LETTERS

p73 Expression Is Regulated by RNPC1, a Target of the p53 Family, via mRNA Stability

(2012) W. Yan et al.   MOLECULAR AND CELLULAR BIOLOGY

MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability

(2012) E Xu et al.   ONCOGENE

Emerging roles of RNA and RNA-binding protein network in cancer cells

(2011) Mee-Young Kim et al.   BMB Reports

Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas

(2011) J. Zhang et al.   GENES & DEVELOPMENT

p53 and its mutants in tumor cell migration and invasion

(2011) Patricia A. J. Muller et al.   JOURNAL OF CELL BIOLOGY

RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability

(2010) S. J. Cho et al.   NUCLEIC ACIDS RESEARCH

RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability

(2010) J. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reactivation of p53: from peptides to small molecules

(2010) Christopher J. Brown et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

(2008) Y. J. Yoon et al.   CARCINOGENESIS